Lam Research Corporation filed an 8-K with the U.S. Securities and Exchange Commission on August 27, 2026, disclosing that two members of its Board of Directors notified the company of their decisions to retire effective November 2, 2026.
George Kurtz, President and CEO of CrowdStrike Holdings, Inc. (NASDAQ:CRWD), filed a Form 4 on August 27, 2026, disclosing the sale of Class A common stock across multiple transactions on August 25 and August 26, 2026, pursuant to a Rule 10b5-1 plan.
Roivant Sciences Ltd. filed a Form 8-K on August 27, 2026, disclosing that the U.S. Food and Drug Administration approved the New Drug Application for LISRAYA (brepocitinib) for the treatment of adults with dermatomyositis.
A Form 4 filed on August 27, 2026, discloses that Adrian T. Dillon, a director of HealthEquity, Inc. (NASDAQ:HQY), exercised stock options and sold shares of common stock on August 25, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.
Standard Nuclear, Inc. (NYSE:STDN) filed its Form 10-Q for the quarterly period ended June 30, 2026, disclosing share counts, IPO details, facility status, and key business arrangements.
IREN Limited filed its Annual Report on Form 10-K with the U.S. Securities and Exchange Commission on August 27, 2026, covering the fiscal year ended June 30, 2026.
Workday, Inc. filed its Form 10-Q for the quarterly period ended July 31, 2026, with the Securities and Exchange Commission, disclosing unaudited financial results for the three and six months ended July 31, 2026.
Jacobo Ortiz Blanes, Chief Operating Officer of Fermi Inc. (NASDAQ:FRMI), filed a Form 4 on August 27, 2026, disclosing the acquisition of 147,059 restricted stock units granted on August 20, 2026, at no cost under the company's 2025 Long-Term Incentive Plan.
Charles F. Willis IV, Executive Chairman of Willis Lease Finance Corp, filed a Form 4 on August 27, 2026, disclosing the sale of common stock on August 25 and August 26, 2026, pursuant to a Rule 10b5-1 trading plan.
Srini Medi, Chief Legal Officer and Secretary of Phoenix Education Partners, Inc. (NYSE:PXED), filed a Form 4 on August 27, 2026, disclosing two transactions in the company's common stock dated August 25, 2026.